Scanning and combinatorial library services – Save 20% with code TRY-BXPLIB-20

mRNA's Untapped Potential: How to Engineer and Optimize Design for Immunotherapy

On-Demand Webinar

Watch this on-demand webinar to gain in-depth knowledge about the mRNA synthesis solutions powered by the BioXp®, including the differences and applications of mRNA De novo and mRNA Select Synthesis kits. The session will also emphasize the strategic importance of rapid DNA template acquisition and its direct impact on the efficiency and effectiveness of research. Plus, get a sneak peek into a success story that demonstrates the tangible benefits of these pioneering approaches.

What You'll Learn:

  • The strategic edge mRNA offers over traditional viral transduction methods.
  • Detailed insights into BioXp de novo and Select mRNA synthesis kits and their applicability for immunotherapy.
  • The significance of rapid DNA template synthesis and its influence on research outcomes.

Presenter:

Pavel Ryzhov

Pavel Ryzhov, PhD

Field Application Scientist
Telesis Bio

Before his tenure at Telesis Bio, Dr. Ryzhov earned his PhD in Biomedical Sciences from the Sanford Burnham Prebys Institute. During his doctoral studies, he delved deep into the realm of oncogenic protein synthesis and characterization. Following his PhD, Dr. Ryzhov took on a role at Applied Photophysics, where he honed his expertise in spectroscopic instrumentation, specifically for macromolecular characterization.

Contact us

The expertise of our scientists, engineers and supporting teams are at your service! Submit the form below and/or call us at 858.526.3080.

Your personal data is handled according to our privacy policy. In accordance with California data privacy laws, California residents may obtain information about the categories of personal information we are collecting and the purposes for which personal information is collected and used here: California Privacy Policy. In addition, if you are located within a distributor territory, you may be contacted directly by them.